#efsitora ผลการค้นหา
⬅️ فئة جديدة من الأنسولين القاعدي طويل المفعول يتم حقنها مرة واحدة في الأسبوع وهي فعالة مثل حقن الأنسولين القاعدي اليومية للتحكم بالسكر في الدم بشكل فعال وآمن لدى مرضى السكري من النوع الثاني. ❇️ إنسولين #إفسيتورا_ألفا (#efsitora) من شركة إيلي ليلي الأمريكية هو إنسولين قاعدي
La insulina #efsitora es una insulina basal de dosis semanal en desarrollo. Una proteína de fusión que combina una insulina de cadena única con un dominio Fc de IgG2 humana. Estudios clínicos han demostrado que puede reducir los niveles de HgA1C de manera comparable a #degludec.
A NEW class of insulin that is injected once a week is as effective as daily insulin injections for effective and safe blood sugar management in patients with type 2 diabetes Insulin efsitora alfa (#efsitora) is a new basal insulin designed for once-weekly administration. 1/
⬅️ تم في مؤتمر الجمعية الأوروبية لدراسة داء السكري المنعقد في مدريد نشر نتائج المرحلة الثالثة من دراسة QWINT-2 تم مقارنة بين عقار أنسولين قاعدي يؤخذ مرة واحدة في الأسبوع #efsitora وبين أنسولين قاعدي يؤخذ مرة كل يوم #degludec ⬅️ للبالغين المصابين بداء السكري من النوع الثاني
In the phase 3 QWINT-2 trial, adults with type 2 diabetes who had not previously received insulin were assigned to receive once-weekly efsitora or once-daily degludec. Efsitora was noninferior to degludec in reducing glycated hemoglobin levels. #EASD2024
@ATTDconf @MadderJules Great time “learning” from our own lectures in this amazing molecules #icodec and #efsitora
“When less is more: the case of weekly basal insulin in diabetes” Here we review available evidence on weekly insulin #icodec #efsitora @DiabetologiaJnL @StefanoCiardul2 @roby_trevisan link.springer.com/content/pdf/10…
#ADA2025: Weekly Fixed-Dose #Insulin #Efsitora in #Type2Diabetes without Previous Insulin Therapy #EliLilly #MedTwitter #Obesity nejm.org/doi/full/10.10…
#insulin #Efsitora by @EliLillyandCo is a once-weekly basal insulin that appears to have low risk for #hypo with #exercise in #T2D based on this excellent study
📌 #QWINT-1: Weekly insulin #efsitora vs daily glargine in #T2D (insulin-naïve) 🗓️ 1 vs 7 injections/week 📉 HbA1c: −1.19% vs −1.16% 🎯 HbA1c <7%: 57% vs 52% ⚠️ 43% ↓ significant hypoglycemia 💉 Median dose: 28 IU/week vs 20 IU/day @NEJM 🔗 doi.org/10.1056/NEJMoa…
#insulinasemanal #onceweeklyinsulin #efsitora #ADA2025 en #diabetestipo2 @drfherediaz @rafael52987 @DrVinodEndo @ENDOCRINO_COL @alejoromanmd @CristobMorales @endocatracha @alfonsomora81 @markinho_gc @RodolfoJGalindo @MWeintraubMD cada vez mas cerca
Review summarises the available evidence on once-weekly insulins for the treatment of type 1 and type 2 #diabetes #icodec #efsitora @StefanoCiardul2 @roby_trevisan tinyurl.com/3zr7yc3d 🔓
Honored to be a part of #RSSDI2024 as a speaker. Delivered a lecture on #QwintTrials, about "Once in a week insulin #Efsitora". Thanks @Rssdi_official Dr. JK sharma @aegleclinic @vijayviswanatha @DrBMMakkar @banshisaboo @dkc1234 @AnujMah51145112
Should everyone switch from once-daily insulins to #icodec or #efsitora? #EASD Board Member @MadderJules lets you know who would benefit from once-weekly #insulins, discussing the latest data (#QWINT2) in this Expert Insights ep. Watch here👉easd-elearning.eu/Expert_Insight… #diabetes
Eli Lilly Reports Data from Two P-III (QWINT-2 and QWINT-4) Studies of Efsitora for Treating Type 2 Diabetes #elililly #efsitora #type2diabetes #clinicaltrial #phase3 #safety #efficacy #t2d #treatment pharmashots.com/17435/eli-lill…
Regardless of the type of #insulin used (#icodec/#efsitora/#glargine), the more reduction of the #HbA1c you achieve, the more #weight you gain. Curious to know how #IcoSema will show in this slide 🤔 #ADA2023
En el #blogdemateu llega una novedad importante 💉#Efsitora, insulina semanal. Menos inyecciones, similar efecto a insulina degludec. (Estudio #QWINT2) ✍️ del Dr. Javier Díez Espino (@DiezEspino) Leer en ⤵️ redgedaps.blogspot.com/2024/10/efsito…
🔔In a first-of-its-kind fixed dose study, once weekly insulin #efsitora alfa leads to A1C reduction similar to daily insulin Eli Lilly and Company (NYSE: $LLY) today announced positive topline results from the QWINT-1 and QWINT-3 phase 3 clinical trials evaluating once weekly
Insulina settimanale #Efsitora alfa: stesso rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
📰 Una nuova insulina chiamata #Efsitora alfa (Efsitora) può essere presa solo una volta a settimana e potrebbe rappresentare una nuova opzione per le persone con #diabete di tipo 2 ➜📱 cardiolinksalute.it/news/una-nuova… #CardioLink #Salute 🩺
📰 Un recente studio ha confrontato una nuova #insulina, chiamata #Efsitora alfa, con l’insulina glargine, in pazienti con diabete di tipo 2 (T2D) ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
📰 Una nuova insulina chiamata #Efsitora alfa (Efsitora) può essere presa solo una volta a settimana e potrebbe rappresentare una nuova opzione per le persone con #diabete di tipo 2 ➜📱 cardiolinksalute.it/news/una-nuova… #CardioLink #Salute 🩺
Insulina settimanale #Efsitora alfa: stesso rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
#Insulina settimanale #Efsitora alfa: nessun aumento del rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
📰 Una nuova insulina chiamata #Efsitora alfa (Efsitora) può essere presa solo una volta a settimana e potrebbe rappresentare una nuova opzione per le persone con #diabete di tipo 2 ➜📱 cardiolinksalute.it/news/una-nuova… #CardioLink #Salute
#Insulina settimanale #Efsitora alfa: stesso rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
cardiolinksalute.it
Insulina settimanale Efsitora alfa: stesso rischio di ipoglicemia rispetto alla glargine
Uno studio recente ha confrontato una nuova insulina, chiamata Efsitora alfa, con l'insulina glargine, in persone con diabete di tipo
#Insulina settimanale #Efsitora alfa: nessun aumento del rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
📰 Una nuova insulina chiamata #Efsitora alfa (Efsitora) può essere presa solo una volta a settimana e potrebbe rappresentare una nuova opzione per le persone con #diabete di tipo 2 ➜📱 cardiolinksalute.it/news/una-nuova… #CardioLink #Salute da #condividere❤️
Insulina settimanale #Efsitora alfa: stesso rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
cardiolinksalute.it
Insulina settimanale Efsitora alfa: stesso rischio di ipoglicemia rispetto alla glargine
Uno studio recente ha confrontato una nuova insulina, chiamata Efsitora alfa, con l'insulina glargine, in persone con diabete di tipo
#Insulina settimanale #Efsitora alfa: nessun aumento del rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
📌 #QWINT-1: Weekly insulin #efsitora vs daily glargine in #T2D (insulin-naïve) 🗓️ 1 vs 7 injections/week 📉 HbA1c: −1.19% vs −1.16% 🎯 HbA1c <7%: 57% vs 52% ⚠️ 43% ↓ significant hypoglycemia 💉 Median dose: 28 IU/week vs 20 IU/day @NEJM 🔗 doi.org/10.1056/NEJMoa…
La insulina #efsitora es una insulina basal de dosis semanal en desarrollo. Una proteína de fusión que combina una insulina de cadena única con un dominio Fc de IgG2 humana. Estudios clínicos han demostrado que puede reducir los niveles de HgA1C de manera comparable a #degludec.
From #ADA2025 - Once-weekly, fixed-dose insulin #efsitora has been found noninferior to insulin #glargine at reducing glycated hemoglobin levels in people with #T2D. Full story 👉 buff.ly/xjwKO77 #MedNews #Insulin
📰 Una nuova insulina chiamata #Efsitora alfa (Efsitora) può essere presa solo una volta a settimana e potrebbe rappresentare una nuova opzione per le persone con #diabete di tipo 2 ➜📱 cardiolinksalute.it/news/una-nuova… #CardioLink #Salute
Insulina settimanale #Efsitora alfa: stesso rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
cardiolinksalute.it
Insulina settimanale Efsitora alfa: stesso rischio di ipoglicemia rispetto alla glargine
Uno studio recente ha confrontato una nuova insulina, chiamata Efsitora alfa, con l'insulina glargine, in persone con diabete di tipo
#Insulina settimanale #Efsitora alfa: nessun aumento del rischio di ipoglicemia rispetto alla glargine ➜📱 cardiolinksalute.it/news/insulina-… #CardioLink #Salute 🩺 L'Informazione Medico Scientifica da #condividere❤️
Eli Lilly plans to submit efsitora, its once-weekly insulin for type 2 diabetes, to global regulators by end-2026 following positive Phase 3 trial outcomes. #EliLilly #Efsitora #Insulin #Diabetes | @koul_sanket mybs.in/2enq82h
business-standard.com
Eli Lilly's weekly insulin efsitora shows positive results in Phase 3
The company plans to submit efsitora, its once-weekly insulin for type 2 diabetes, to global regulators by end-2026 following positive Phase 3 trial outcomes: Eli Lilly efsitora
#insulinasemanal #onceweeklyinsulin #efsitora #ADA2025 en #diabetestipo2 @drfherediaz @rafael52987 @DrVinodEndo @ENDOCRINO_COL @alejoromanmd @CristobMorales @endocatracha @alfonsomora81 @markinho_gc @RodolfoJGalindo @MWeintraubMD cada vez mas cerca
#ADA2025: Weekly Fixed-Dose #Insulin #Efsitora in #Type2Diabetes without Previous Insulin Therapy #EliLilly #MedTwitter #Obesity nejm.org/doi/full/10.10…
⬅️ فئة جديدة من الأنسولين القاعدي طويل المفعول يتم حقنها مرة واحدة في الأسبوع وهي فعالة مثل حقن الأنسولين القاعدي اليومية للتحكم بالسكر في الدم بشكل فعال وآمن لدى مرضى السكري من النوع الثاني. ❇️ إنسولين #إفسيتورا_ألفا (#efsitora) من شركة إيلي ليلي الأمريكية هو إنسولين قاعدي
La insulina #efsitora es una insulina basal de dosis semanal en desarrollo. Una proteína de fusión que combina una insulina de cadena única con un dominio Fc de IgG2 humana. Estudios clínicos han demostrado que puede reducir los niveles de HgA1C de manera comparable a #degludec.
📌 #QWINT-1: Weekly insulin #efsitora vs daily glargine in #T2D (insulin-naïve) 🗓️ 1 vs 7 injections/week 📉 HbA1c: −1.19% vs −1.16% 🎯 HbA1c <7%: 57% vs 52% ⚠️ 43% ↓ significant hypoglycemia 💉 Median dose: 28 IU/week vs 20 IU/day @NEJM 🔗 doi.org/10.1056/NEJMoa…
⬅️ تم في مؤتمر الجمعية الأوروبية لدراسة داء السكري المنعقد في مدريد نشر نتائج المرحلة الثالثة من دراسة QWINT-2 تم مقارنة بين عقار أنسولين قاعدي يؤخذ مرة واحدة في الأسبوع #efsitora وبين أنسولين قاعدي يؤخذ مرة كل يوم #degludec ⬅️ للبالغين المصابين بداء السكري من النوع الثاني
In the phase 3 QWINT-2 trial, adults with type 2 diabetes who had not previously received insulin were assigned to receive once-weekly efsitora or once-daily degludec. Efsitora was noninferior to degludec in reducing glycated hemoglobin levels. #EASD2024
Review summarises the available evidence on once-weekly insulins for the treatment of type 1 and type 2 #diabetes #icodec #efsitora @StefanoCiardul2 @roby_trevisan tinyurl.com/3zr7yc3d 🔓
“When less is more: the case of weekly basal insulin in diabetes” Here we review available evidence on weekly insulin #icodec #efsitora @DiabetologiaJnL @StefanoCiardul2 @roby_trevisan link.springer.com/content/pdf/10…
En el #blogdemateu llega una novedad importante 💉#Efsitora, insulina semanal. Menos inyecciones, similar efecto a insulina degludec. (Estudio #QWINT2) ✍️ del Dr. Javier Díez Espino (@DiezEspino) Leer en ⤵️ redgedaps.blogspot.com/2024/10/efsito…
#insulinasemanal #onceweeklyinsulin #efsitora #ADA2025 en #diabetestipo2 @drfherediaz @rafael52987 @DrVinodEndo @ENDOCRINO_COL @alejoromanmd @CristobMorales @endocatracha @alfonsomora81 @markinho_gc @RodolfoJGalindo @MWeintraubMD cada vez mas cerca
@ATTDconf @MadderJules Great time “learning” from our own lectures in this amazing molecules #icodec and #efsitora
Honored to be a part of #RSSDI2024 as a speaker. Delivered a lecture on #QwintTrials, about "Once in a week insulin #Efsitora". Thanks @Rssdi_official Dr. JK sharma @aegleclinic @vijayviswanatha @DrBMMakkar @banshisaboo @dkc1234 @AnujMah51145112
A NEW class of insulin that is injected once a week is as effective as daily insulin injections for effective and safe blood sugar management in patients with type 2 diabetes Insulin efsitora alfa (#efsitora) is a new basal insulin designed for once-weekly administration. 1/
#insulin #Efsitora by @EliLillyandCo is a once-weekly basal insulin that appears to have low risk for #hypo with #exercise in #T2D based on this excellent study
#ADA2025: Weekly Fixed-Dose #Insulin #Efsitora in #Type2Diabetes without Previous Insulin Therapy #EliLilly #MedTwitter #Obesity nejm.org/doi/full/10.10…
Eli Lilly Reports Data from Two P-III (QWINT-2 and QWINT-4) Studies of Efsitora for Treating Type 2 Diabetes #elililly #efsitora #type2diabetes #clinicaltrial #phase3 #safety #efficacy #t2d #treatment pharmashots.com/17435/eli-lill…
🔔In a first-of-its-kind fixed dose study, once weekly insulin #efsitora alfa leads to A1C reduction similar to daily insulin Eli Lilly and Company (NYSE: $LLY) today announced positive topline results from the QWINT-1 and QWINT-3 phase 3 clinical trials evaluating once weekly
Something went wrong.
Something went wrong.
United States Trends
- 1. Iran N/A
- 2. Iran N/A
- 3. Operation Epic Fury N/A
- 4. Middle East N/A
- 5. Bahrain N/A
- 6. Tehran N/A
- 7. Iraq N/A
- 8. Netanyahu N/A
- 9. Qatar N/A
- 10. Good Saturday N/A
- 11. Kuwait N/A
- 12. IRGC N/A
- 13. Saudi Arabia N/A
- 14. Ayatollah N/A
- 15. Abu Dhabi N/A
- 16. Death to America N/A
- 17. WWIII N/A
- 18. Persia N/A
- 19. Troops N/A
- 20. World War 3 N/A